Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY

OBJECTIVE: To evaluate the effect of upadacitinib (UPA) monotherapy vs MTX on patient-reported outcomes (PROs) in patients with RA who were MTX-naïve or who had an inadequate response to MTX (MTX-IR). METHODS: PROs from the SELECT-EARLY and SELECT-MONOTHERAPY randomized controlled trials were evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Strand, Vibeke, Tundia, Namita, Wells, Alvin, Buch, Maya H, Radominski, Sebastiao C, Camp, Heidi S, Friedman, Alan, Suboticki, Jessica L, Dunlap, Kendall, Goldschmidt, Debbie, Bergman, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516509/
https://www.ncbi.nlm.nih.gov/pubmed/33313898
http://dx.doi.org/10.1093/rheumatology/keaa770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516509/
https://www.ncbi.nlm.nih.gov/pubmed/33313898
http://dx.doi.org/10.1093/rheumatology/keaa770

Ejemplares similares